The #ASH19 poster hall game involves sipping your 🍺 each time you see a title that contains the phrase “real world” or “real life”. 😉

Cop a ‘tude!!! CARTITUDE -1: JNJ-4528 with 100% ORR AND CR 69% !! ‘Nuff said

FDA approves GSK’s BLENREP (belantamab mafodotin-blmf) for the treatment of patients with relapsed or refractory multiple myeloma #mmsm ⁦Multiple Myeloma RF⁩ ⁦International Myeloma Foundation⁩ gsk.com/en-gb/media/pr…

Higher CR rate does not always translate to improved OS. Important to consider below before changing SOC.

"Anyone else who recklessly squandered lives and money in this way would be suffering legal consequences. Our leaders have largely claimed immunity for their actions. But this election gives us the power to render judgment" nejm.org/doi/full/10.10…

BREAKING: Joe Biden has been elected the 46th president of the United States, according to the AP — narrowly beating President Trump after a turbulent race. More here: trib.al/tKWPedk

Hospitals in Ohio are approaching full occupancy. Cleveland Clinic is postponing nonessential surgeries and prepping contingency plans to redeploy caregivers to the care of #COVID patients. I am worried. Mask up. 😷 Don’t gather. |⬅️6️⃣➡️| We can do this, people.

I believe this it what my patients mean when they tell me they have 'mareos'. A dizzying array of options in triple-class refractory myeloma. #mmsm

Big news for AL amyloidosis. Now we need to continue education to improve diagnosis

Breaking News: lde-cel (Abecma; idecabtagene vicleucel), approved by FDA for multiple myeloma. This is the first CAR-T therapy for myeloma. Many patients have been waiting for this good news. Amit Agarwal BMS Myeloma bluebird bio news.bms.com/news/corporate…

The housing market right now is making me slowly lose my mind.

"It’s easy to judge, but it’s better to be curious, because we don’t have all the answers".👍🏽article by Conor Friedersdorf on the importance of 𝒗𝒊𝒆𝒘𝒑𝒐𝒊𝒏𝒕 𝒅𝒊𝒗𝒆𝒓𝒔𝒊𝒕𝒚 in the diversity/inclusion conversation The Atlantic tinyurl.com/5dx9y6u6

FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide): go.usa.gov/xFZRx

Finally, the manuscript for Part 2 CASSIOPEIA trial (Dara Maint. vs Obs.) is out!! Extremely glad that there was a 2𝒏𝒅 𝒓𝒂𝒏𝒅𝒐𝒎𝒊𝒛𝒂𝒕𝒊𝒐𝒏 instead of automatically continuing Dara Mx in Dara-VTD arm. My take on the results 🧵1/10 The Lancet #mmsm tinyurl.com/u3jbs2vt

I’d like to sign up for the every 3 month booster study now please.

2022 TANDEM meeting postponed until April astct.org/attend/tandem-…

Unprecedented Advances Fuel Progress in the Treatment of AL Amyloidosis Jack Khouri Cleveland Clinic #oncology #hematology ow.ly/Qf1R50I4nR3

Waiting to hear if I can go to work today. My daycare has too many staff out due to covid to open every classroom. This is such an unsustainable way to parent/work/live, and it’s been going on for years now.

A beautiful graduation celebration for our 2022-2023 residents. So proud and appreciative of their hard work - especially my PGY1s! Special thank you to Mandy Leonard for her mentorship and advocacy for our residency programs! #proudRPD #TwitteRx Cleveland Clinic Pharmacy Residency Programs #7under27